1-112918054-CAATAAATAAATAAATAAATAAATA-CAATAAATAAATA
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_003051.4(SLC16A1):c.362-22_362-11delTATTTATTTATT variant causes a intron change. The variant allele was found at a frequency of 0.0181 in 857,606 control chromosomes in the GnomAD database, including 240 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.016 ( 23 hom., cov: 0)
Exomes 𝑓: 0.018 ( 217 hom. )
Consequence
SLC16A1
NM_003051.4 intron
NM_003051.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.97
Genes affected
SLC16A1 (HGNC:10922): (solute carrier family 16 member 1) The protein encoded by this gene is a proton-linked monocarboxylate transporter that catalyzes the movement of many monocarboxylates, such as lactate and pyruvate, across the plasma membrane. Mutations in this gene are associated with erythrocyte lactate transporter defect. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 1-112918054-CAATAAATAAATA-C is Benign according to our data. Variant chr1-112918054-CAATAAATAAATA-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 212184.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1, Benign=2}.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0161 (2322/144598) while in subpopulation NFE AF= 0.0173 (1148/66406). AF 95% confidence interval is 0.0165. There are 23 homozygotes in gnomad4. There are 1171 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 23 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC16A1 | NM_003051.4 | c.362-22_362-11delTATTTATTTATT | intron_variant | ENST00000369626.8 | NP_003042.3 | |||
SLC16A1 | NM_001166496.2 | c.362-22_362-11delTATTTATTTATT | intron_variant | NP_001159968.1 | ||||
SLC16A1 | XM_047428789.1 | c.362-22_362-11delTATTTATTTATT | intron_variant | XP_047284745.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC16A1 | ENST00000369626.8 | c.362-22_362-11delTATTTATTTATT | intron_variant | 1 | NM_003051.4 | ENSP00000358640.4 |
Frequencies
GnomAD3 genomes AF: 0.0160 AC: 2319AN: 144526Hom.: 23 Cov.: 0
GnomAD3 genomes
AF:
AC:
2319
AN:
144526
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00795 AC: 483AN: 60732Hom.: 19 AF XY: 0.00807 AC XY: 288AN XY: 35678
GnomAD3 exomes
AF:
AC:
483
AN:
60732
Hom.:
AF XY:
AC XY:
288
AN XY:
35678
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0185 AC: 13180AN: 713008Hom.: 217 AF XY: 0.0181 AC XY: 6543AN XY: 360876
GnomAD4 exome
AF:
AC:
13180
AN:
713008
Hom.:
AF XY:
AC XY:
6543
AN XY:
360876
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0161 AC: 2322AN: 144598Hom.: 23 Cov.: 0 AF XY: 0.0167 AC XY: 1171AN XY: 70192
GnomAD4 genome
AF:
AC:
2322
AN:
144598
Hom.:
Cov.:
0
AF XY:
AC XY:
1171
AN XY:
70192
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 03, 2023 | - - |
Hyperinsulinism, Dominant Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 22, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at